Results 241 to 250 of about 280,561 (284)
Some of the next articles are maybe not open access.

INTRAVITREAL DEXAMETHASONE IMPLANTATION FOR BIRDSHOT CHORIORETINOPATHY

RETINAL Cases & Brief Reports, 2017
Purpose: Birdshot chorioretinopathy is a rare form of posterior uveitis. This article reports a case series of patients with HLA-A29+ birdshot chorioretinopathy managed with intravitreal dexamethasone implants.
James, Walsh, Ashvini K, Reddy
openaire   +2 more sources

Safety of 6000 intravitreal dexamethasone implants

British Journal of Ophthalmology, 2019
PurposeTo evaluate the real-life safety profile of intravitreal dexamethasone implant injection for various retinal conditions.MethodsRetrospective multicenter analysis of intravitreal dexamethasone implant injections (700 µg) due to various retinal conditions including central retinal venous occlusion (1861 injections), diabetic macular oedema (3104 ...
Masarwa, Dua   +144 more
openaire   +7 more sources

Endophthalmitis After Dexamethasone Implant

Clinical & Experimental Ophthalmology
ABSTRACT Background The dexamethasone intravitreal implant is used to treat sight‐threatening retinal disorders. Endophthalmitis is a serious complication of intravitreal injections and requires urgent intervention.
Maryam Eghtedari   +4 more
openaire   +2 more sources

Dexamethasone Intravitreal Implant (Ozurdex)

Canadian Journal of Health Technologies, 2023
CADTH recommends that Ozurdex not be reimbursed by public drug plans for the treatment of adult patients with diabetic macular edema (DME) who are pseudophakic and have had an inadequate response to prior anti–vascular endothelial growth factor (VEGF) therapy. Evidence from 1 clinical trial and 2 observational studies was insufficient to demonstrate
openaire   +1 more source

PERSISTENT REMNANTS OF DEXAMETHASONE INTRAVITREAL IMPLANT (OZURDEX)

Retina, 2020
Purpose: To describe persistent remnants of dexamethasone intravitreal implant (DEX implant) and evaluate the risk factors for remnant persistence in patients who received a DEX implant. Methods: This retrospective observational study involved a retrospective chart review of 133 ...
Jee Taek, Kim   +2 more
openaire   +2 more sources

Multicomponent Implant Releasing Dexamethasone

AIP Conference Proceedings, 2008
Several inflammatory conditions are usually treated with corticosteroids. There are various problems like side effects with traditional applications of steroids, e.g. topical, or systemic routes. Local drug delivery systems have been studied and developed to gain more efficient administration with fewer side effects.
L. Nikkola   +8 more
openaire   +1 more source

MIGRATION OF INTRAVITREAL DEXAMETHASONE IMPLANT TO ANTERIOR CHAMBER

RETINAL Cases & Brief Reports, 2013
Purpose: To describe two cases of migration of intravitreally injected dexamethasone implant into the anterior chamber. Methods: Charts were reviewed of two patients who received sustained-release dexamethasone implant intravitreally for chronic intractable cystoid macular edema.
Vamsi K, Gullapalli, David A, DiLoreto
openaire   +2 more sources

Late Migration of Dexamethasone Implant Into Anterior Chamber

Archives of Ophthalmology, 2012
1942;28(4):613-631. doi:10.1001/archopht.1942.00880100047004. 12. Karpe G. Basis of clinical electroretinography. Acta Ophthalmol (Copenh). 1945; 24(suppl):84. 13. Bjork A, Karpe G. The electroretinogram in retinitis pigmentosa. Acta Ophthalmol (Copenh). 1951;29:361-376. 14. Verhoeff FH. Microscopic observations in a case of retinitis pigmentosa.
Kevin M, Cronin   +2 more
openaire   +2 more sources

Management of Anterior Chamber Dislocation of a Dexamethasone Implant

Klinische Monatsblätter für Augenheilkunde, 2019
Abstract Purpose To characterise the surgical removal technique of a dislocated dexamethasone implant in the anterior chamber and to gauge its success by analysing corneal transparency and subsequent visual acuity recovery in the postoperative phase.
Nguyen TL, Wolfensberger TJ
openaire   +3 more sources

Repositioning and follow-up of intralenticular dexamethasone implant

Journal of Cataract and Refractive Surgery, 2013
We report the case of a 54-year-old man who attended our emergency department complaining of severe floaters and decreased vision in his right eye. Seven days earlier, a dexamethasone intravitreal implant (Oxurdex) had been placed for a noninfectious posterior uveitis.
Mihnea, Munteanu, Cosmin, Rosca
openaire   +2 more sources

Home - About - Disclaimer - Privacy